Singapore is already recognised as a key biomedical hub in Asia, making it an ideal location to bring stake-holders from across Asia-Pacific together in open dialogue.

In keeping pace with scientific development, innovations in regulation have the opportunity to reach large audiences through Singapore’s strategic position, especially with the number of biomedical bodies and pharmaceutical and medical device companies based in this country.